tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Treace Medical cuts Fy23 revenue view to $182M-$186M from $191M-$197M

Consensus $194.3M. The Company “expects positive adjusted EBITDA in the fourth quarter of 2023 and continues to expect to show modest improvement in adjusted EBITDA for full-year 2023 compared to 2022.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on TMCI:

Disclaimer & DisclosureReport an Issue

1